455 related articles for article (PubMed ID: 25441255)
41. Increased (18)F-fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography/computed tomography (PET/CT): accumulated data from four years of experience with PET/CT.
Metser U; Even-Sapir E
Semin Nucl Med; 2007 May; 37(3):206-22. PubMed ID: 17418153
[TBL] [Abstract][Full Text] [Related]
42. Deciphering PDT-induced inflammatory responses using real-time FDG-PET in a mouse tumour model.
Cauchon N; Hasséssian HM; Turcotte E; Lecomte R; van Lier JE
Photochem Photobiol Sci; 2014 Oct; 13(10):1434-43. PubMed ID: 25058054
[TBL] [Abstract][Full Text] [Related]
43. Fluorine-18-deoxyglucose positron emission tomography/computed tomography with Ki67 and GLUT-1 immunohistochemistry for evaluation of the radiosensitization effect of oleanolic acid on C6 rat gliomas.
Zhang Y; Xu H; Wang H; Yu W; Zhao X; Xue Y
Nucl Med Commun; 2015 Jan; 36(1):21-7. PubMed ID: 25222909
[TBL] [Abstract][Full Text] [Related]
44. The reverse Warburg effect and 18F-FDG uptake in non-small cell lung cancer A549 in mice: a pilot study.
Zhang G; Li J; Wang X; Ma Y; Yin X; Wang F; Zheng H; Duan X; Postel GC; Li XF
J Nucl Med; 2015 Apr; 56(4):607-12. PubMed ID: 25722447
[TBL] [Abstract][Full Text] [Related]
45. Experimental study on the therapeutic effect of positron emission tomography agent [¹⁸F]-labeled 2-deoxy-2-fluoro-d-glucose in a colon cancer mouse model.
Fang S; Wang J; Jiang H; Zhang Y; Xi W; Zhao C; Tian M; Zhang H
Cancer Biother Radiopharm; 2010 Dec; 25(6):733-40. PubMed ID: 21204768
[TBL] [Abstract][Full Text] [Related]
46. What can be seen by 18F-FDG PET in atherosclerosis imaging? The effect of foam cell formation on 18F-FDG uptake to macrophages in vitro.
Ogawa M; Nakamura S; Saito Y; Kosugi M; Magata Y
J Nucl Med; 2012 Jan; 53(1):55-8. PubMed ID: 22128324
[TBL] [Abstract][Full Text] [Related]
47. Effects of intratumoral inflammatory process on 18F-FDG uptake: pathologic and comparative study with 18F-fluoro-α-methyltyrosine PET/CT in oral squamous cell carcinoma.
Kim M; Achmad A; Higuchi T; Arisaka Y; Yokoo H; Yokoo S; Tsushima Y
J Nucl Med; 2015 Jan; 56(1):16-21. PubMed ID: 25476535
[TBL] [Abstract][Full Text] [Related]
48. Biodistribution and uptake of 3'-deoxy-3'-fluorothymidine in ENT1-knockout mice and in an ENT1-knockdown tumor model.
Paproski RJ; Wuest M; Jans HS; Graham K; Gati WP; McQuarrie S; McEwan A; Mercer J; Young JD; Cass CE
J Nucl Med; 2010 Sep; 51(9):1447-55. PubMed ID: 20720035
[TBL] [Abstract][Full Text] [Related]
49. Noninvasive
Henry KE; Dilling TR; Abdel-Atti D; Edwards KJ; Evans MJ; Lewis JS
J Nucl Med; 2018 Jan; 59(1):51-57. PubMed ID: 28848040
[TBL] [Abstract][Full Text] [Related]
50. Pictorial review of
Ishibashi M; Tanabe Y; Fujii S; Ogawa T
Ann Nucl Med; 2017 Jul; 31(6):437-453. PubMed ID: 28585058
[TBL] [Abstract][Full Text] [Related]
51. Correlation between ¹⁸F-FDG uptake and the expression of glucose transporter-1 and hypoxia-inducible factor-1α in transplanted VX2 tumors.
Xu H; Li B; Yu W; Wang H; Zhao X; Yao Y; Huang D
Nucl Med Commun; 2013 Oct; 34(10):953-8. PubMed ID: 23887273
[TBL] [Abstract][Full Text] [Related]
52. Preclinical dynamic 18F-FDG PET - tumor characterization and radiotherapy response assessment by kinetic compartment analysis.
Røe K; Aleksandersen TB; Kristian A; Nilsen LB; Seierstad T; Qu H; Ree AH; Olsen DR; Malinen E
Acta Oncol; 2010 Oct; 49(7):914-21. PubMed ID: 20831478
[TBL] [Abstract][Full Text] [Related]
53. 18F-FDG uptake on PET in primary mediastinal non-thymic neoplasm: a clinicopathological study.
Kaira K; Abe M; Nakagawa K; Ohde Y; Okumura T; Takahashi T; Murakami H; Shukuya T; Kenmotsu H; Naito T; Hayashi I; Oriuchi N; Endo M; Kondo H; Nakajima T; Yamamoto N
Eur J Radiol; 2012 Sep; 81(9):2423-9. PubMed ID: 22055682
[TBL] [Abstract][Full Text] [Related]
54. 18F-FDG PET/CT monitoring of β3 agonist-stimulated brown adipocyte recruitment in white adipose tissue.
Park JW; Jung KH; Lee JH; Quach CH; Moon SH; Cho YS; Lee KH
J Nucl Med; 2015 Jan; 56(1):153-8. PubMed ID: 25525187
[TBL] [Abstract][Full Text] [Related]
55. Impact of animal handling on the results of 18F-FDG PET studies in mice.
Fueger BJ; Czernin J; Hildebrandt I; Tran C; Halpern BS; Stout D; Phelps ME; Weber WA
J Nucl Med; 2006 Jun; 47(6):999-1006. PubMed ID: 16741310
[TBL] [Abstract][Full Text] [Related]
56. Comparison of conventional and novel PET tracers for imaging mesothelioma in nude mice with subcutaneous and intrapleural xenografts.
Tsuji AB; Sogawa C; Sugyo A; Sudo H; Toyohara J; Koizumi M; Abe M; Hino O; Harada YN; Furukawa T; Suzuki K; Saga T
Nucl Med Biol; 2009 May; 36(4):379-88. PubMed ID: 19423005
[TBL] [Abstract][Full Text] [Related]
57. Detection of melanoma metastases with PET-Comparison of
Wang Y; Li M; Zhang Y; Zhang F; Liu C; Song Y; Zhang Y; Lan X
Nucl Med Biol; 2017 Jul; 50():33-38. PubMed ID: 28433794
[TBL] [Abstract][Full Text] [Related]
58. Relationship between 18F-FDG accumulation and lactate dehydrogenase A expression in lung adenocarcinomas.
Zhou X; Chen R; Xie W; Ni Y; Liu J; Huang G
J Nucl Med; 2014 Nov; 55(11):1766-71. PubMed ID: 25342384
[TBL] [Abstract][Full Text] [Related]
59. 18F-FES and 18F-FDG PET for differential diagnosis and quantitative evaluation of mesenchymal uterine tumors: correlation with immunohistochemical analysis.
Zhao Z; Yoshida Y; Kurokawa T; Kiyono Y; Mori T; Okazawa H
J Nucl Med; 2013 Apr; 54(4):499-506. PubMed ID: 23471314
[TBL] [Abstract][Full Text] [Related]
60. Downregulation of microRNA-29 by antisense inhibitors and a PPAR-gamma agonist protects against myocardial ischaemia-reperfusion injury.
Ye Y; Hu Z; Lin Y; Zhang C; Perez-Polo JR
Cardiovasc Res; 2010 Aug; 87(3):535-44. PubMed ID: 20164119
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
